AUS
NZ
UK
CA
USA
IND
News
88 Energy (ASX:88E) announces a prospective resource estimate of 1.03 billion barrels for Icewine East
August 10, 2022 03:49 PM AEST| By Nitish KumarAlaska-focused oil explorer,88 Energy Limited (,ASX:88E,),is going from strength to strength at its Project Icewine East, following an independent resource assessment announcement yesterday.,In an upbeat market update, the company announced an enormo...
Cooper Metals Limited (ASX:CPM) secures AU$2.55M in firm commitments
August 10, 2022 12:34 PM AEST| By AkshayCooper has secured firm commitments worth AU$2.55 million (before costs) to place 5.67 million shares at an issue price of AU$0.45 a share.,Shares of CPM traded at AU$$0.48 a share on 9 August 2022, zooming 5.5% against the previous close,Cooper inte...
Tenement acquisition, capital raise plans send Cooper Metals (ASX:CPM) shares soaring
August 10, 2022 12:28 PM AEST| By AkshayCooper has signed of a Binding Heads of Agreement (HOA) for the acquisition of an exploration tenement, EPM19125.,The new tenement includes zones that require immediate exploration follow-up, including two historical copper mines and historical rock...
ASX 200 falls on tech losses; A2 Milk dips over 7%
August 10, 2022 10:51 AM AEST| By AshishThe Australian share market opened marginally lower on Wednesday following weak cues from Wall Street.
Aspire Mining (ASX:AKM) continues momentum on Mongolian project in Q4 with crucial FEED Studies
August 10, 2022 10:40 AM AEST| By Nitish KumarHighlights,Aspire Mining concluded FEED studies on the coal handling and preparation plant and the Erdenet Rail Terminal during the June quarter.,The company submitted the Feasibility Study of connecting roads between Ovoot and Erdenet for review to...
ASX 200 to fall ahead of US inflation data; CBA results ahead
August 10, 2022 08:02 AM AEST| By AshishThe Australian share market is likely to begin on a muted note on Wednesday, tracking weakness on Wall Street
Reserve Rights (RSR) crypto’s volume shoots up over 300%. Here's why
August 09, 2022 05:36 PM AEST| By Manu ShankarThe RSR token on 9 August witnessed a rally of 3.71%, along with a volume gain of 300% at 7:00 AM (GMT +1), according to CoinMarketCap.
Renegade (ASX:RNX) reports assay result, confirms broad zones of copper at Lady Agnes
August 09, 2022 04:16 PM AEST| By Nitish KumarHighlights,Renegade Resources hit broad zones of copper-gold intercepts from the recently concluded drilling campaign.,The company continues its exploration momentum on the project with extensive geophysical explorations underway to delineate drillin...
ASX 200 closes in green; telecom gains, utilities fall
August 09, 2022 04:09 PM AEST| By Bhawna GuptaTelecom Services was the best performing sector today, gaining 1.73%. The sector has gained 2% in last five trading days.
Dimerix (ASX:DXB) files patent family application for COPD candidate
August 09, 2022 12:33 PM AEST| By Aditi SarkarHighlights,Dimerix has taken a crucial step towards bolstering its IP position.,The biopharmaceutical company has announced a new patent family application for DMX-700 for COPD.,DMX-700 achieved a statistically significant 80% reduction versus contro...
S&P/ASX Australian Stock Market Trading Index Hits All-Time High in 2022
August 09, 2022 12:17 PM AEST| By Matt Gelberman (Guest)The Australian trading market is full of different types of trading. For example,,Plus500 Australia,is one of Australia's best mobile CFD platforms where you can trade S&P/ASX 200, Bitcoin, AUD/USD & ANZ. Among those different types of trading, the S...
ASX 200 opens higher; Materials & Information Technology lead gains
August 09, 2022 10:37 AM AEST| By Khushboo JoshiHighlights,ASX 200 benchmark index was marginally higher, up 5.80 points at 7,026.40 at 10:23 AM AEST today (9 August 2022).,In last five trading days, the index has gained 0.40%.,The market has been taking cues from the Wall Street that ended on a r...
Radiopharm (ASX:RAD) partners with Lantheus and NanoMab; know more
August 09, 2022 10:34 AM AEST| By Aditi SarkarHighlights,Radiopharm has joined hands with Lantheus to develop a nanobody.,The company is set to start a Phase 1 therapeutic trial in patients with NSCLC.,Radiopharm gained the imaging rights of the nanobody from NanoMab for China.,Radiopharm Theran...
Radiopharm’s (ASX:RAD) June quarter sees major portfolio boost and team additions
August 09, 2022 10:28 AM AEST| By Aditi SarkarHighlights,Radiopharm’s progress during the June quarter was marked by major agreements, technology additions and new appointments.,The company gained access to brain tumour technology, high-quality medical isotope, and promising LRRC15 antibody.,RAD...
Saunders (ASX:SND) boosts orderbook with new projects worth $24M
August 09, 2022 10:12 AM AEST| By Nitish KumarHighlights,Saunders International has won new projects worth AU$24 million.,The new projects from diverse sectors will contribute to the company’s revenue and earnings during FY23.,The company is in the process of finalising five more projects valued...
ASX 200 to open lower on mixed US closing; Megaport, NAB in focus
August 09, 2022 07:59 AM AEST| By AshishThe Australian shares are expected to fall at the open on Tuesday, tracking weak cues from Wall Street.
Why is Perpetual Protocol (PERP) crypto dipping today?
August 08, 2022 05:56 PM AEST| By Manu ShankarThe PERP crypto on 8 August witnessed a loss of 1.65% at 6:00 AM (GMT +1) and a volume loss of over 30%, according to CoinMarketCap
ASX 200 closes marginally up; energy, materials sectors lead gains
August 08, 2022 04:33 PM AEST| By Bhawna Gupta• The ASX 200 benchmark index closed up today, increased 0.071% to end at 7,020.60 points.
Neuren (ASX:NEU) initiates Phase 2 trials of NNZ-2591
August 08, 2022 04:19 PM AEST| By Aditi SarkarNeuren Pharmaceuticals (ASX:NEU) has started enrolment for Phase 2 clinical trials of its second drug candidate, NNZ-2591 in PMS and PTHS.
Imugene (ASX:IMU) Presents New PD1-Vaxx Data at 2022 WCLC
August 08, 2022 03:03 PM AEST| By ManishaHighlights,Imugene Limited (ASX:IMU) has presented new data from non-small cell lung cancer patients in the Phase I IMPRINTER study at the IASLC 2022 World Conference on Lung Cancer.,The IMPRINTER trial is an ongoing open-label dose escalation study...
Advertise your brand on Kalkine Media